Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Idebenone for primary progressive multiple sclerosis
New data analyses show significant clinical and MRI improvements with PLEGRIDY™ (peginterferon beta-1a)
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab.
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination.
Analysis: Healthy babies born after accelerated elimination of teriflunomide
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
[Nicolau syndrome after administration of glatiramer acetate].
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
U.S. Food and Drug Administration approval: ofatumumab for the treatment of patients with chronic lymphocytic leukemia refractory to fludarabine and alemtuzumab.
The mystery of missing heritability: Genetic interactions create phantom heritability.
Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
[Intractable vomiting as first manifestation of neuromyelitis Optica.]
Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.
Application of fullerenes in nanomedicine: an update.
4-aminopyridine toxicity: a case report and review of the literature.
Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years.
Dynamic regulatory network controlling TH17 cell differentiation.
Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling.
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis.
Gut microbiota composition and relapse risk in pediatric MS: A pilot study.
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?

Pages